Xtant Story

<div class='circular--portrait' style='background:#FF0000;color: #F8F8FF;font-size:4em;'>XM</div>
XTNT -- USA Stock  

USD 1.91  0.01  0.52%

In spite of comparatively inconsistent basic indicators, Xtant Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. Xtant Medical Holdings moves totally opposite to the market. We can now break down Xtant as a potential investment option for your portfolios.
Published over a month ago
View all stories for Xtant Medical | View All Stories
Does Xtant Medical (AMEX:XTNT) have stable basic indicators based on the newest gain?
We provide recommendation to complement the prevalent expert consensus on Xtant Medical Holdings. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Xtant Medical income statement, its balance sheet, and the statement of cash flows. Potential Xtant Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may use each financial statement separately, they are all related. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Xtant Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Xtant Medical fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Xtant Medical performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Xtant Medical shares is the value that is considered the true value of the share. If the intrinsic value of Xtant is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Xtant Medical.
Please read more on our fundamental analysis page.

What is Xtant Asset Breakdown?

Xtant Medical Holdings reports assets on its Balance Sheet. It represents the amount of Xtant resources that either has an existing economic value or will provide some form of benefits in the future. To get a better handle on how balance sheet or income statements item affect Xtant volatility, please check the breakdown of all its fundamentals

How Xtant utilizes its cash?

To perform a cash flow analysis of Xtant Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Xtant Medical is receiving and how much cash it distributes out in a given period. The Xtant Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Xtant Medical Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Xtant Medical reported Net Cash Flow from Operations of (16.57 Million) in 2020

Xtant Medical Gross Profit

Xtant Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Xtant Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Xtant Medical Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

Breaking it down a bit more

Institutional investors typically avoid acquiring a high percentage of Xtant Medical stocks because performing such an act may violate securities laws. They are usually not investing their own money, but rather making investments on behalf of their clients. Let's take a look at how the ownership of Xtant is distributed among investors.

Ownership Allocation

Xtant Medical Holdings owns a total of 76.86 Million outstanding shares. The majority of Xtant Medical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Xtant Medical Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Xtant Medical Holdings. Please pay attention to any change in the institutional holdings of Xtant Medical Holdings as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Retail Investors1.78

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xtant Medical has an asset utilization ratio of 39.91 percent. This implies that the company is making $0.4 for each dollar of assets. An increasing asset utilization means that Xtant Medical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
47.6 M
Assets Non Current
93.2 M
79.4 M
Current Assets47.57 Million21.6
Assets Non Current93.21 Million42.33
Goodwill79.4 Million36.06

Our take on today Xtant Medical gain

The kurtosis is down to 0.84 as of today. Xtant Medical Holdings exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Xtant Medical Holdings individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Xtant Medical future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Xtant Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Xtant Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

The Current Takeaway on Xtant Medical Investment

Whereas many other companies under the medical devices industry are still a bit expensive, Xtant Medical may offer a potential longer-term growth to private investors. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to short some or all of your Xtant Medical holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Xtant Medical.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Xtant Medical Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com